Global Melanoma Therapeutics Market Overview:
“The global Melanoma Therapeutics Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
Melanoma is a form of skin cancer that arises when pigment-producing cells mutates and become cancerous. Pigmented cells are found in skin and occur in other part of body such as intestine, and eyes. Melanoma is one of type of skin cancer which is less common than basal cell and squamous cell skin cancer. However, melanoma is considered as dangerous type of skin cancer as these cancerous growths develop when unrepaired DNA damage to skin cells and they are likely to spread in the body. Melanoma is caused due to exposure to ultraviolet radiation form the sun and from tanning lamp.
Increasing prevalence of melanoma, skin allergies and skin cancer is expected to drive the growth of melanoma therapeutics market. Moreover, rising awareness about the melanoma globally, coupled with several government and non-profit organizations providing education and support services is anticipated to further drive growth of the global melanoma therapeutics market over the forecast period. Furthermore, increasing number of approvals for novel therapeutics is expected to boost the growth of melanoma therapeutics market over the forecast period.
A major factor restraining growth of the global melanoma therapeutics market is high cost for treatment.
However, technological advancements and innovations focusing on development of biologics for treatments is expected to create new opportunities for major players in the global melanoma therapeutics market over the forecast period.
North America market dominates the global melanoma therapeutics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of skin cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global melanoma therapeutics market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively.
The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for cost-efficient therapeutics.
Global Melanoma Therapeutics Market Segmentation:
Global melanoma therapeutics market segmentation, by therapy type:
- Targeted therapy
- Radiation therapy
- Other novel therapies (Virus based, Adjuvant therapy)
Global melanoma therapeutics market segmentation, by stage:
- Stage 0 (Melanoma in Situ)
- Stage I
- Stage II
- Stage III
- Stage IV
Global melanoma therapeutics market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Amgen, Inc.
- Hoffman-La Roche Ltd.
- Bristol-Myers Squibb Company
- Novartis AG
- Merck & Co., Inc.
- AB Sciences
- Celgene Corporation
- Galectin Therapeutics
- Ziopharm Oncology, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!